Inventor · disambiguated record
Jens Schröder
Also filed as: SCHRODER JENS · SCHRODER JENS-MICHAEL · SCHROEDER JENS · SCHROEDER JENS-M
17 granted patents·22 pending applications·126 citations·filing 1991–2024
92Inventor score
Top patents by PatentIndex Score
39 records- 0183US5795883AAndrogens and anabolic agentsJENAPHARM GMBH·Filed 1994·Granted Aug 18, 1998·40 cites·12 claims
- 0277US9682974B2Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Granted Jun 20, 2017·4 cites·8 claims
- 0375US9745285B2Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Granted Aug 29, 2017·3 cites·5 claims
- 0474US12227501B23-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one as CSNK1 inhibitorsBAYER AG·Filed 2020·Granted Feb 18, 2025·1 cites·15 claims
- 0574US9765058B2Substituted benzylpyrazolesBayer Pharma AG·Filed 2014·Granted Sep 19, 2017·3 cites·14 claims
- 0673US5464822APolypeptides and polypeptide analoguesZENECA LTD·Filed 1992·Granted Nov 7, 1995·23 cites·3 claims
- 0772US7419781B1Human antibiotic proteinsPLANTON GMBH·Filed 2000·Granted Sep 2, 2008·6 cites·7 claims
- 0871US2025136599A14h-pyrrolo[3,2-c]pyridin-4-one compoundsBAYER AG·Filed 2024·Application pending·0 cites
- 0966US10350206B2Benzyl substituted indazoles as BUB1 inhibitorsBayer Pharma AG·Filed 2015·Granted Jul 16, 2019·1 cites·28 claims
- 1061US5914325ASteroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substancesJENAPHARM GMBH·Filed 1994·Granted Jun 22, 1999·15 cites·4 claims
- 1161US2016046604A1Heteroaryl substituted indazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 1260US2023416249A1N-[2-({4-[3-(anilino)-4-oxo-4,5,6,7-tetrahydro-1h-pyrrolo[3,2-c]pyridin-2-yl]pyridin-3-yl)oxy)ethyl]prop-2-enamide derivatives and similar compounds as egfr inhibitors for the treatment of cancerBAYER AG·Filed 2023·Application pending·0 cites
- 1359US2016052912A1Diaminoheteroaryl substituted indazolesBAYER PHARMA AKITIENGESELLSCHAFT·Filed 2014·Application pending·0 cites
- 1457US2024247015A1Phosphorus derivatives as novel sos1 inhibitorsBAYER AG·Filed 2022·Application pending·0 cites
- 1556US11479587B2Cationic intrinsically disordered antimicrobial peptidesUNIV KIEL CHRISTIAN ALBRECHTS·Filed 2017·Granted Oct 25, 2022·0 cites·9 claims
- 1656US6255279B1Cosmetic preparations containing vertebrate proteins and having antibacterial, antimycotical and antiviral actionBEIERSDORF AG·Filed 1996·Granted Jul 3, 2001·20 cites·8 claims
- 1756US2023064983A13-(anilino)-2-[3-(3-alkoxy-pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one derivatives as egfr inhibitors for the treatment of cancerBAYER AG·Filed 2022·Application pending·0 cites
- 1854US2022298157A14h-pyrrolo[3,2-c]pyridin-4-one compoundsBAYER AG·Filed 2020·Application pending·0 cites
- 1954US2025120647A1Monitoring the disease progression of a parkinson's patientBAYER AG·Filed 2023·Application pending·0 cites
- 2053US2022235013A12-methyl-quinazolinesBayer Pharma AG·Filed 2018·Application pending·0 cites
- 2151US2016046610A13-heteroaryl substituted indazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2251US2017283396A1Diaminoheteroaryl substituted indazolesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2351US2006068480A1Polypeptides and polypeptide analoguesOLIVER WIEDOW·Filed 2005·Application pending·0 cites
- 2448US12403135B24H-pyrrolo[3,2-c]pyridin-4-one derivativesBAYER AG·Filed 2020·Granted Sep 2, 2025·0 cites·16 claims
- 2548US2022227729A1Identification and use of kras inhibitorsBAYER AG·Filed 2020·Application pending·0 cites
- 2647US6893843B2Nucleic acidsFiled 2001·Granted May 17, 2005·0 cites·7 claims
- 2746US2024307362A14H-PYRROLO[3,2-c]PYRIDIN-4-ONE COMPOUNDSBAYER AG·Filed 2020·Application pending·0 cites
- 2845US2017275268A1Heteroaryl substituted indazolesBayer Pharma AG·Filed 2017·Application pending·0 cites
- 2944US2016145267A1Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3044US2016168130A1Heteroaryl substituted pyrazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3142US2016151370A1Substituted BenzylpyrazolesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3241US5977096ASteroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substancesJENAPHARM GMBH·Filed 1999·Granted Nov 2, 1999·4 cites·2 claims
- 3340US10894784B2Heteroarylbenzimidazole compoundsBayer Pharma AG·Filed 2016·Granted Jan 19, 2021·0 cites·15 claims
- 3438US6245739B1polypeptides and polypeptide analoguesWIEDOW OLIVER·Filed 1995·Granted Jun 12, 2001·4 cites·4 claims
- 3535US5234911ASubstance with interleukin-8 inhibiting activity and process for its preparationGIST BROCADES NV·Filed 1991·Granted Aug 10, 1993·2 cites·4 claims
- 3635US2017275269A1Benzyl substituted indazoles as bub1 kinase inhibitorsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3735US2017275270A1Benzyl substituted indazolesBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3835US2017305882A1Benzyl substituted indazoles as bub1 kinase inhibitorsBayer Pharma AG·Filed 2015·Application pending·0 cites
- 3932US2012238533A1(Heteroarylmethyl) Thiohydantoins as anticancer drugsCLEVE ARWED·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →